Details for New Drug Application (NDA): 202278

✉ Email this page to a colleague

NDA 202278 describes ZECUITY, which is a drug marketed by Teva Branded Pharm and is included in one NDA. There are nine patents protecting this drug. Additional details are available on the ZECUITY profile page.

The generic ingredient in ZECUITY is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

Summary for 202278

Tradename:	ZECUITY
Applicant:	Teva Branded Pharm
Ingredient:	sumatriptan succinate
Patents:	9

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SYSTEM;IONTOPHORESIS			Strength	EQ 6.5MG BASE/4HR
Approval Date:	Jan 17, 2013	TE:		RLD:	Yes
Patent:	⤷ Get Started Free	Patent Expiration:	Apr 12, 2027	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
Patent:	⤷ Get Started Free	Patent Expiration:	Apr 12, 2027	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
Patent:	⤷ Get Started Free	Patent Expiration:	Apr 21, 2029	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A FLOWABLE HYDROGEL FORMULATION

Expired US Patents for NDA 202278

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	ZECUITY	sumatriptan succinate	SYSTEM;IONTOPHORESIS	202278-001	Jan 17, 2013	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.